Nettetfor 1 dag siden · Featured Investigator: José A. Bauermeister, MPH, PhD. Faculty Director, eidos LGBTQ+ Health Initiative at University of Pennsylvania Nettet14. apr. 2024 · Target Audience and Goal Statement. This activity is intended for oncologists, pathologists, pulmonologists, nurses/nurse practitioners (NPs), physician assistants (PAs), and pharmacists. The goal of this activity is for the learner to be better able to individualize care for patients with non-small cell lung cancer (NSCLC) and …
Cisplatin versus cetuximab with definitive concurrent radiotherapy …
Nettet26. mai 2015 · Although many cancer patients use complementary and alternative medicine, what drives this usage is unclear. To investigate, a team led by Jun Mao, MD and Joshua Bauml, MD, of the Abramson Cancer Center at the University of Pennsylvania’s Perelman School of Medicine, conducted a survey-based study in their … Nettet27. mar. 2024 · Emerging Horizons in Cancer Immunotherapy Immunotherapy has been shown to be beneficial in the first- and second-line setting for multiple solid tumor types. The quickly changing landscape of available therapies and indications can make selection and use of immunotherapies challenging. ff550043g
Clinical Implications of Plasma-Based Genotyping With the …
Nettet5. aug. 2024 · In a special OncLive video program, The Board, Joshua M. Bauml, MD, assistant professor of medicine, Perelman School of Medicine, University of Pennsylvania, led a discussion regarding key... NettetMedical Oncology at MD.com. Joshua Bauml is a Medical Oncology at MD.com based in Cherry Hill, New Jersey. Read More. Contact. Joshua Bauml's Phone Number and … Nettet19. jul. 2024 · Joshua Bauml, MD: Anyway, if I did not have access to osimertinib, then your 2 options to add to a first-generation TKI, based upon the data that we saw today and the data we’ve seen in the past ... ff5488 filtro